282 related articles for article (PubMed ID: 28959067)
21. Safety and immunogenicity of a toddler dose following an infant series of a hexavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b, hepatitis B vaccine administered concurrently or at separate visits with a heptavalent pneumococcal conjugate vaccine.
Halperin SA; Tapiéro B; Dionne M; Meekison W; Diaz-Mitoma F; Zickler P; Rubin E; Embree J; Bhuyan P; Lee A; Li M; Tomovici A
Pediatr Infect Dis J; 2014 Jan; 33(1):73-80. PubMed ID: 24346596
[TBL] [Abstract][Full Text] [Related]
22. Immunogenicity and reactogenicity of a combined fully liquid DTPw-HepB-Hib pentavalent vaccine in healthy infants: no clinically relevant impact of a birth dose of hepatitis B vaccine.
Gentile A; Umido V; Czerniuk P; Nacul J; Seigelchifer M; Hilbert AK; Yela U; Herzog C; Aeberhard U; Spyr C
Int J Infect Dis; 2011 Jan; 15(1):e24-9. PubMed ID: 21093342
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis B immune memory in children primed with hexavalent vaccines and given monovalent booster vaccines: an open-label, randomised, controlled, multicentre study.
Zanetti AR; Romanò L; Giambi C; Pavan A; Carnelli V; Baitelli G; Malchiodi G; Valerio E; Barale A; Marchisio MA; Montù D; Tozzi AE; D'Ancona F;
Lancet Infect Dis; 2010 Nov; 10(11):755-61. PubMed ID: 20884297
[TBL] [Abstract][Full Text] [Related]
24. Primary vaccination of infants with diphtheria-tetanus-acellular pertussis-hepatitis B virus- inactivated polio virus and Haemophilus influenzae type b vaccines given as either separate or mixed injections.
Schmitt HJ; Knuf M; Ortiz E; Sänger R; Uwamwezi MC; Kaufhold A
J Pediatr; 2000 Sep; 137(3):304-12. PubMed ID: 10969252
[TBL] [Abstract][Full Text] [Related]
25. A new DTPw-HB/Hib combination vaccine for primary and booster vaccination of infants in Latin America.
Tregnaghi M; López P; Rocha C; Rivera L; David MP; Rüttimann R; Schuerman L
Rev Panam Salud Publica; 2006 Mar; 19(3):179-88. PubMed ID: 16640847
[TBL] [Abstract][Full Text] [Related]
26. Immunogenicity and reactogenicity of two regimens of diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio and Haemophilus influenzae type b vaccines administered to infants primed at birth with hepatitis B vaccine.
Cheng HK; Rajadurai VS; Amin Z; Sriram B; Yee MF; Han HH; Bock HL; Safary A
Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):685-92. PubMed ID: 15689088
[TBL] [Abstract][Full Text] [Related]
27. Immunological persistence in 4-6 and 7-9 year olds previously vaccinated in infancy with hexavalent DTPa-HBV-IPV/Hib.
Zinke M; Disselhoff J; ; Gartner B; Jacquet JM
Hum Vaccin; 2010 Feb; 6(2):189-93. PubMed ID: 20009522
[TBL] [Abstract][Full Text] [Related]
28. Immunogenicity and safety of an indigenously manufactured reconstituted pentavalent (DTwP-HBV+Hib) vaccine in comparison with a foreign competitor following primary and booster immunization in Indian children.
Sharma HJ; Yadav S; Lalwani SK; Kapre SV; Jadhav SS; Chakravarty A; Parekh SS; Palkar S; Bhardwaj SH; Namjoshi GS; Verma V
Hum Vaccin; 2011 Apr; 7(4):451-7. PubMed ID: 21403463
[TBL] [Abstract][Full Text] [Related]
29. Booster immunization with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate combination vaccine in the second year of life: safety, immunogenicity and persistence of antibody responses.
Heininger U; ; ; Sänger R; Jacquet JM; Schuerman L
Vaccine; 2007 Jan; 25(6):1055-63. PubMed ID: 17049692
[TBL] [Abstract][Full Text] [Related]
30. Immunogenicity and reactogenicity of DTPa-HBV-IPV/Hib vaccine as primary and booster vaccination in low-birth-weight premature infants.
Vázquez L; Garcia F; Rüttimann R; Coconier G; Jacquet JM; Schuerman L
Acta Paediatr; 2008 Sep; 97(9):1243-9. PubMed ID: 18489623
[TBL] [Abstract][Full Text] [Related]
31. Persistence of protection to hepatitis B vaccine and response to booster dose among children and adolescents in Dakahleya- Egypt.
Salama II; Sami SM; Salama SI; Foud WA; Abdel Hamid AT; Said ZN
Egypt J Immunol; 2014; 21(1):13-26. PubMed ID: 25204041
[TBL] [Abstract][Full Text] [Related]
32. Safety and immunogenicity of two Haemophilus influenzae type b polysaccharide-tetanus toxoid conjugate vaccines (PRP-T) given with diphtheria-tetanus-pertussis vaccine to young Papua New Guinean children.
Lehmann D; Kakazo M; Saleu G; Taime J; Javati A; Namuigi P; Alpers MP; Wegmüller B; Zellmeyer M; Fürer E; Que JU; Herzog C
P N G Med J; 2001; 44(1-2):6-16. PubMed ID: 12418673
[TBL] [Abstract][Full Text] [Related]
33. Fragmentation of scheduled visits and missed doses among infants receiving multiple injected vaccines.
Ferson MJ; McKenzie KA; Macartney-Bourne F
Aust N Z J Public Health; 1997 Dec; 21(7):735-8. PubMed ID: 9489191
[TBL] [Abstract][Full Text] [Related]
34. Antibody persistence, PRP-specific immune memory, and booster responses in infants immunised with a combination DTPa-HBV-IPV/Hib vaccine.
Nolan T; Altmann A; Skeljo M; Streeton C; Schuerman L
Vaccine; 2004 Nov; 23(1):14-20. PubMed ID: 15519702
[TBL] [Abstract][Full Text] [Related]
35. Immune response to hepatitis B vaccine following complete immunization of children attending two regional hospitals in the Southwest region of Cameroon: a cross sectional study.
Anutebeh EN; Tatah L; Feteh VF; Aroke D; Assob JCN; Choukem SP
BMC Infect Dis; 2021 Dec; 21(1):1205. PubMed ID: 34856942
[TBL] [Abstract][Full Text] [Related]
36. Infant vaccination timing: Beyond traditional coverage metrics for maximizing impact of vaccine programs, an example from southern Nepal.
Hughes MM; Katz J; Englund JA; Khatry SK; Shrestha L; LeClerq SC; Steinhoff M; Tielsch JM
Vaccine; 2016 Feb; 34(7):933-41. PubMed ID: 26788880
[TBL] [Abstract][Full Text] [Related]
37. Anti-HBs Titers Following Pentavalent Immunization (DTwP-HBV-Hib) in Term Normal Weight vs Low Birthweight Infants.
Verma C; Faridi MM; Narang M; Kaur IR
Indian Pediatr; 2018 May; 55(5):395-399. PubMed ID: 29428913
[TBL] [Abstract][Full Text] [Related]
38. Impact of a birth dose of hepatitis B vaccine on the reactogenicity and immunogenicity of diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b combination vaccination.
Pichichero ME; Blatter MM; Reisinger KS; Harrison CJ; Johnson CE; Steinhoff MC; Senders SD; Rothstein EP; Willems P; Howe BJ
Pediatr Infect Dis J; 2002 Sep; 21(9):854-9. PubMed ID: 12352809
[TBL] [Abstract][Full Text] [Related]
39. Immunogenicity and safety of a new hexavalent vaccine (DTaP5-IPV-HB-Hib) administered in a mixed primary series schedule with a pentavalent vaccine (DTaP5-IPV-Hib).
Martinón-Torres F; Boisnard F; Thomas S; Sadorge C; Borrow R;
Vaccine; 2017 Jun; 35(30):3764-3772. PubMed ID: 28583305
[TBL] [Abstract][Full Text] [Related]
40. Antibody persistence of two pentavalent DTwP-HB-Hib vaccines to the age of 15-18 months, and response to the booster dose of quadrivalent DTwP-Hib vaccine.
Sharma H; Yadav S; Lalwani S; Kapre S; Jadhav S; Parekh S; Palkar S; Ravetkar S; Bahl S; Kumar R; Shewale S
Vaccine; 2013 Jan; 31(3):444-7. PubMed ID: 23196204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
